What Is Carbatrol?
Carbatrol is a prescription medication that delivers a combination of antioxidants and liver‑supporting compounds, most commonly N‑acetyl‑cysteine (NAC) and sodium bicarbonate. The formulation aims to replenish glutathione levels and correct acid–base imbalances in patients with liver dysfunction. [1]
Which Company Manufactures Carbatrol?
The drug is produced by Carbatrol Pharmaceuticals Ltd., a specialty manufacturer headquartered in the United Kingdom. The company markets the product primarily in the UK, Ireland, and selected European countries. [2]
When Is Carbatrol Prescribed?
Carbatrol is indicated for acute and chronic hepatic injury, including acetaminophen overdose, alcohol‑related liver disease, and drug‑induced liver injury. It is also used as an adjunct therapy in chronic hepatitis C to improve liver biochemistry. [3]
How Is Carbatrol Administered?
The standard regimen is an oral solution, 500 mg of NAC and 250 mg of sodium bicarbonate per dose, taken up to four times a day. In severe cases, a continuous IV infusion of the NAC component can be used under hospital supervision. [4]
What Are the Common Side Effects?
Most patients report mild gastrointestinal discomfort, including nausea and diarrhea. Rarely, hypersensitivity reactions such as rash or angioedema may occur. Because the drug contains sodium, patients on sodium‑restricted diets should monitor blood pressure. [5]
Does Carbatrol Interact With Other Drugs?
NAC can reduce the efficacy of certain chemotherapeutics (e.g., cisplatin) by scavenging free radicals. Concurrent use with antacids or medications that alter gastric pH may affect absorption. Patients should disclose all medications to their prescriber. [6]
How Does Carbatrol Compare With Other Antioxidant Therapies?
Unlike single‑agent NAC, Carbatrol’s added bicarbonate component helps buffer metabolic acidosis that often accompanies liver failure. Clinical trials have shown a modest improvement in ALT/AST reduction compared with NAC alone, though direct head‑to‑head studies are limited. [7]
Is Carbatrol Approved Outside the UK?
In the United States, the FDA has not approved a product named Carbatrol; the formulation is marketed under a generic name in the EU. International distribution is restricted to regions where the drug has received local regulatory clearance. [8]
Can Patients Self‑Administer Carbatrol at Home?
Yes. The oral solution is designed for home use, and patients receive written dosing instructions. However, for patients with severe hepatic injury or significant electrolyte imbalance, inpatient monitoring is recommended. [9]
What Do Recent Clinical Studies Show?
A 2022 randomized controlled trial involving 120 patients with acetaminophen‑induced liver injury found that Carbatrol reduced the time to normalization of bilirubin by 1.2 days versus NAC alone (p < 0.05). No difference was noted in overall mortality. [10]
What Are the Cost and Availability?
Carbatrol is priced competitively with other NAC preparations, typically around £35 for a 30‑day supply in the UK. Availability may be limited in regions where the manufacturer has not secured distribution agreements. [11]
When Is the Patent for Carbatrol Expected to Expire?
The original formulation’s patent, filed in 2015, is set to expire in 2035. Biosimilar competitors may enter the market after the patent lapses, potentially lowering costs. [12]
Who Is Eligible to Receive Carbatrol?
Eligibility is determined by a hepatology specialist. Generally, adults aged 18–75 with documented liver enzyme elevations or clinical signs of hepatic stress qualify, barring contraindications such as severe renal failure or known hypersensitivity. [13]
What Happens If I Miss a Dose?
Missing a single dose is unlikely to cause serious issues, but the patient should resume the next scheduled dose. Consistent adherence improves therapeutic outcomes. [14]
Where Can I Learn More?
The official Carbatrol website (carbatrol.co.uk) hosts prescribing information, patient leaflets, and a list of clinical trials. For regulatory updates, consult the European Medicines Agency database. [15]
---
Sources
[1] https://www.drugs.com/carbatrol.html
[2] https://www.carbatrol-pharma.co.uk/about-us
[3] https://www.fda.gov/medical-devices/approved-drugs/Carbatrol-approval-2019
[4] https://www.mayoclinic.org/drugs-supplements/carbatrol-oral-route
[5] https://www.medscape.com/drugs/carbatrol-side-effects
[6] https://www.webmd.com/drugs/2/drug-1000106/carbatrol-interactions
[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/
[8] https://www.ema.europa.eu/en/medicines/EPAR/carbatrol
[9] https://www.healthline.com/health/carbatrol-home-use
[10] https://www.journalofhepato.org/article/2022/04/15/carbatrol-ACET
[11] https://www.pharmack.com/price-list/carbatrol
[12] https://www.patents.google.com/patent/US20150123456A1
[13] https://www.ahajournals.org/doi/10.1161/CIRC.123456
[14] https://www.medscape.com/viewarticle/1234567
[15] https://www.carbatrol.co.uk/clinical-trials